Insider Stock Trading History of Kovner Bruce


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kovner Bruce since year 2005. The trader's CIK number is 1325713. At the time of this reporting, Kovner Bruce is the of Kala Pharmaceuticals, Inc. . (stock ticker symbol KALA). See this page for all insider trading activities at Kala Pharmaceuticals, Inc. .

Note that in the past Kovner Bruce also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kovner Bruce since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-07-20 KALA Kala Pharmaceuticals, Inc. Buy 215,000 15.00 3,225,000
2015-12-08 SNTA Synta Pharmaceuticals Corp Sale 1,369,639 .37 506,766
2015-12-04 SNTA Synta Pharmaceuticals Corp Sale 153,607 .41 63,286
2015-12-07 SNTA Synta Pharmaceuticals Corp Sale 100 .41 41
2015-12-03 SNTA Synta Pharmaceuticals Corp Sale 262,434 .41 108,647
2015-12-02 SNTA Synta Pharmaceuticals Corp Sale 687,603 .43 293,606
2015-12-01 SNTA Synta Pharmaceuticals Corp Sale 480,716 .43 206,707
2015-11-25 SNTA Synta Pharmaceuticals Corp Sale 1,503,720 .49 733,815
2015-11-27 SNTA Synta Pharmaceuticals Corp Sale 934,595 .49 462,624
2015-11-30 SNTA Synta Pharmaceuticals Corp Sale 640,505 .43 277,979
2015-11-23 SNTA Synta Pharmaceuticals Corp Sale 635,453 .44 277,692
2015-11-24 SNTA Synta Pharmaceuticals Corp Sale 538,129 .44 237,314
2015-11-18 SNTA Synta Pharmaceuticals Corp Sale 108,154 .43 46,830
2015-11-19 SNTA Synta Pharmaceuticals Corp Sale 1,174,651 .48 559,133
2015-11-20 SNTA Synta Pharmaceuticals Corp Sale 230,283 .44 102,015
2015-11-13 SNTA Synta Pharmaceuticals Corp Sale 507,788 .43 219,364
2015-11-16 SNTA Synta Pharmaceuticals Corp Sale 15,530 .43 6,755
2015-11-17 SNTA Synta Pharmaceuticals Corp Sale 700,618 .42 295,660
2015-11-12 SNTA Synta Pharmaceuticals Corp Sale 733,564 .47 347,709
2015-11-11 SNTA Synta Pharmaceuticals Corp Sale 1,080,941 .50 538,308
2015-11-10 SNTA Synta Pharmaceuticals Corp Sale 1,397,114 .55 769,809
2015-11-09 SNTA Synta Pharmaceuticals Corp Sale 2,225,054 .61 1,355,057
2015-04-06 SNTA Synta Pharmaceuticals Corp Buy 6,857,143 1.75 12,000,000
2014-09-30 SNTA Synta Pharmaceuticals Corp Buy 300,000 3.08 923,100
2014-04-11 SNTA Synta Pharmaceuticals Corp Buy 1,250,000 4.01 5,012,500
2013-11-13 SNTA Synta Pharmaceuticals Corp Buy 5,000,000 3.75 18,750,000
2013-06-27 SNTA Synta Pharmaceuticals Corp Buy 150,000 4.71 706,500
2013-06-26 SNTA Synta Pharmaceuticals Corp Buy 300,000 4.65 1,395,899
2013-06-25 SNTA Synta Pharmaceuticals Corp Buy 200,000 4.35 869,400
2013-06-21 SNTA Synta Pharmaceuticals Corp Buy 50,000 4.23 211,500
2013-06-24 SNTA Synta Pharmaceuticals Corp Buy 200,000 4.43 886,000
2013-06-18 SNTA Synta Pharmaceuticals Corp Buy 200,000 4.00 799,200
2013-06-06 SNTA Synta Pharmaceuticals Corp Buy 738,900 4.31 3,186,875
2013-06-05 SNTA Synta Pharmaceuticals Corp Buy 756,000 4.71 3,561,516
2013-06-04 SNTA Synta Pharmaceuticals Corp Buy 505,100 4.99 2,521,459
2012-11-12 SNTA Synta Pharmaceuticals Corp Buy 27,200 6.89 187,435
2012-11-14 SNTA Synta Pharmaceuticals Corp Buy 10,500 6.95 73,006
2012-11-12 SNTA Synta Pharmaceuticals Corp Buy 27,200 6.89 187,435
2012-11-14 SNTA Synta Pharmaceuticals Corp Buy 10,500 6.95 73,006
2012-06-29 SNTA Synta Pharmaceuticals Corp Buy 910,000 5.45 4,959,500
2012-01-06 SNTA Synta Pharmaceuticals Corp Buy 1,136,363 4.40 4,999,997
2011-12-07 SNTA Synta Pharmaceuticals Corp Buy 11,059 3.95 43,727
2011-11-29 SNTA Synta Pharmaceuticals Corp Buy 8,844 3.96 35,022
2011-11-25 SNTA Synta Pharmaceuticals Corp Buy 25,016 3.94 98,462
2011-11-22 SNTA Synta Pharmaceuticals Corp Buy 453 3.96 1,792
2011-11-23 SNTA Synta Pharmaceuticals Corp Buy 7,547 3.98 30,037
2011-11-18 SNTA Synta Pharmaceuticals Corp Buy 21,000 3.71 77,931
2011-11-21 SNTA Synta Pharmaceuticals Corp Buy 33,640 3.84 129,312
2011-09-09 SNTA Synta Pharmaceuticals Corp Buy 110,149 3.77 415,702
2011-09-12 SNTA Synta Pharmaceuticals Corp Buy 43,085 3.82 164,455
2011-09-06 SNTA Synta Pharmaceuticals Corp Buy 50,400 3.79 191,268
2011-09-02 SNTA Synta Pharmaceuticals Corp Buy 46,057 3.89 179,253
2011-08-26 SNTA Synta Pharmaceuticals Corp Buy 100 3.85 385
2011-08-22 SNTA Synta Pharmaceuticals Corp Buy 10,597 3.77 39,961
2011-08-23 SNTA Synta Pharmaceuticals Corp Buy 5,167 3.72 19,226
2011-08-18 SNTA Synta Pharmaceuticals Corp Buy 3,303 3.79 12,511
2011-08-10 SNTA Synta Pharmaceuticals Corp Buy 33,978 3.70 125,582
2011-08-09 SNTA Synta Pharmaceuticals Corp Buy 52,464 3.71 194,641
2011-08-08 SNTA Synta Pharmaceuticals Corp Buy 41,700 3.77 157,334
2011-04-14 SNTA Synta Pharmaceuticals Corp Buy 1,431,493 4.89 7,000,000
2010-09-15 SNTA Synta Pharmaceuticals Corp Buy 24,264 3.64 88,418
2010-09-14 SNTA Synta Pharmaceuticals Corp Buy 38,836 3.70 143,654
2010-09-13 SNTA Synta Pharmaceuticals Corp Buy 36,900 3.57 131,843
2010-06-15 SNTA Synta Pharmaceuticals Corp Buy 65,466 3.91 256,102
2010-06-14 SNTA Synta Pharmaceuticals Corp Buy 2,075 3.42 7,104
2010-06-10 SNTA Synta Pharmaceuticals Corp Buy 26,500 3.00 79,447
2010-06-11 SNTA Synta Pharmaceuticals Corp Buy 59,400 3.22 191,030
2010-06-09 SNTA Synta Pharmaceuticals Corp Buy 88,532 2.92 258,956
2010-06-08 SNTA Synta Pharmaceuticals Corp Buy 26,760 2.80 74,820
2010-01-08 SNTA Synta Pharmaceuticals Corp Buy 550,000 4.50 2,475,000
2008-08-11 SNTA Synta Pharmaceuticals Corp Buy 25,100 7.15 179,465
2008-08-12 SNTA Synta Pharmaceuticals Corp Buy 1,300 7.37 9,579
2007-11-28 INFS Infocus Corp Sale 4,438,200 1.51 6,701,682
2007-06-11 SNTA Synta Pharmaceuticals Corp Buy 34,600 8.57 296,625
2007-06-08 SNTA Synta Pharmaceuticals Corp Buy 35,867 8.29 297,445
2007-02-09 SNTA Synta Pharmaceuticals Corp Buy 720,000 10.00 7,200,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kovner Bruce ( of Kala Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.